Your browser doesn't support javascript.
loading
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA.
Scheipner, Lukas; Tappero, Stefano; Piccinelli, Mattia Luca; Barletta, Francesco; Garcia, Cristina Cano; Incesu, Reha-Baris; Morra, Simone; Baudo, Andrea; Tian, Zhe; Saad, Fred; Shariat, Shahrokh F; Terrone, Carlo; De Cobelli, Ottavio; Briganti, Alberto; Chun, Felix K H; Tilki, Derya; Longo, Nicola; Carmignani, Luca; Pichler, Martin; Hutterer, Georg; Ahyai, Sascha; Karakiewicz, Pierre I.
  • Scheipner L; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. l.scheipner@medunigraz.at.
  • Tappero S; Department of Urology, Medical University of Graz, Auenbruggerpl. 1, 8036, Graz, Austria. l.scheipner@medunigraz.at.
  • Piccinelli ML; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Barletta F; Department of Urology, IRCCS Policlinico San Martino, Genoa, Italy.
  • Garcia CC; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genoa, Italy.
  • Incesu RB; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Morra S; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Baudo A; Università Degli Studi di Milano, Milan, Italy.
  • Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Saad F; Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Shariat SF; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Terrone C; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
  • De Cobelli O; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Briganti A; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Chun FKH; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Tilki D; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, 80131, Naples, Italy.
  • Longo N; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Carmignani L; Department of Urology, IRCCS Policlinico San Donato, Milan, Italy.
  • Pichler M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Hutterer G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
  • Ahyai S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Karakiewicz PI; Department of Urology, Weill Cornell Medical College, New York, NY, USA.
World J Urol ; 41(11): 2991-3000, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37755519

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article